Global Branded Generics Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application

A branded generic is a drug that is bioequivalent to the original product, but is now marketed under another company's brand name. Branded generics are an attractive business for Valeant’s Emerging Markets operations as they enjoy low research and development costs and sustainable sales.
North America accounts for the largest market size of branded generics in 2017 and is projected to lead the market over the forecast period of 2018 to 2025.

Market Analysis and Insights: Global Branded Generics Market
The global Branded Generics market size is projected to reach US$ 309.4 million by 2026, from US$ 219.2 million in 2020, at a CAGR of 5.9% during 2021-2026.
Global Branded Generics Scope and Segment
The global Branded Generics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Branded Generics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2015 to 2020. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.

Segment by Type, the Branded Generics market is segmented into
Oral
Parenteral
Topical
Other

Segment by Application, the Branded Generics market is segmented into
Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases

Branded Generics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Branded Generics business, the date to enter into the Branded Generics market, Branded Generics product introduction, recent developments, etc.
The major vendors covered:
Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Bausch Health

Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Branded Generics markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Branded Generics market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.

Frequently Asked Questions